Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > My opinion

<< Previous

Bullboard Posts

Next >>

Post by Momo25on Oct 03, 2021 12:06am

468 Views

Post# 33958279

My opinion

I am not a scientist and I don't care about the science per say. I care about the money I have invested in this company when the share was at $15. I am still above 6$ a share in average . TH executives have no clue about the shareholders Return Of Investment. I see some of you trying to justify Paul's and the board attitudes. Those are a gang of losers not business men.

<< Previous

Bullboard Posts

Next >>

Top 10 pharmaceutical AI stocks